15Mar 2023
Exploring the Role of Early Anakinra Therapy in Multisystem Inflammatory Syndrome in Children

Exploring the Role of Early Anakinra Therapy in Multisystem Inflammatory Syndrome in Children

The study aimed to evaluate the effectiveness of interleukin‐1 receptor antagonism in treating Multisystem Inflammatory Syndrome in Children (MIS‐C). The researchers conducted a retrospective cohort study of MIS‐C cases in the US from November 2020 to December 2021. They found that there was substantial variation in initial anakinra use in a real-world population of children with MIS‐C. However, they did not observe any significant short-term improvement in cardiovascular outcomes associated with early addition of anakinra to IVIG and/or glucocorticoids compared to IVIG and glucocorticoids alone.

  • #rheumatology

Like

Save

Share